Gadunan, Chin Zyrine M.
HRN: 23-51-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2023
CEFUROXIME 750MG (VIAL)
08/06/2023
08/13/2023
IVT
600mg
Q8
Sti Sec To Va, Laceratd Wound Face Sec To Va
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes